Download Centre

Speaker Industry Insight

• Back to the Future - Pharmacovigilance in China
  Both Pharmacovigilance (PV) and Pharmacoepidemiology (PE) are still young specialties in China.
  PE was introduced into China in late 80’s or early 90’s. In 1992, the professional journal, Chinese Journal of Pharmacoepidemilogy, was publicly issued.
• Electronic Health Record set to improve Chinese Pharmacovigilance by 2020
  Guo Xiaojun, Associate Director-Patient Safety, AstraZeneca R&D China, speaks to Pharma IQ Editor Bryan Camoens on the current state of Pharmacovigilance in China and how pharmacovigilnace in China will evolve by the year 2020.
• Technology will lead to drastic changes for Pharmacovigilance in China
  Dr. Wang Da You, Chief Pharmacist for Hua Shan Hospital, - the teaching hospital for Fudan Universtiy – speaks to Bryan Camoens on the challenges facing the Pharmacovigilance sector in China. He also outlines the key factors that must be taken into account when trying to establish Pharmacovigilance harmonization in China.
• China may remain a specific case until it is able to take the lead in the region
  Jean Christophe Delumeau, Head of PharmacovigilanceAsia-Pacific for Bayer Healthcare Global R&D Center speaks exclusively to Pharma IQ Editor on the evolution of Pharmacovigilance over the next decade.

---

Pharmacovigilance Market Intelligence

• Developing Advanced Comprehensive Pharmacovigilance System For Asia
  Jean-Christophe Delumeau, Head of Pharmacovigilance in Asia-Pacific for Bayer HealthCare, Beijing discusses the advanced comprehensive Pharmacovigilance System and what must be done to reach such a goal.
• The importance of Pharmacovigilance in Asia
  Prof Paul S. Lalvani, Dean and Director of Empower School of Health explains the importance of pharmacovigilance in Asia and gives his take on why pharmacovigilance is vitally important for Asia.
• Harmonization in Pharmacovigilance
  Y.K. Gupta, Professor and Head of the Department of Pharmacology at the All India Institute of Medical Sciences outlines the importance of a harmonised regulatory system and its benefits to the pharmaceutical industry. He also discusses the differential rate of developmental progress in countries across Asia and the impact and role of harmonization and its role in ASEAN.

[ Register Now ]